Made-in-Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials
Made-in-Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials
First dose of ETC-159 administered in Phase 1B of clinical trials, advancing the development of this drug to treat solid tumours
Scientists from the Experimental Drug Development Centre, A*STAR, preparing ETC-159 clinical samples for real-time Reverse Transcription-Polymerase Chain Reaction (RT-PCR) which amplifies the genetic material. (Photo credit: A*STAR)
Scientists from the…
View On WordPress













